Sarana Meditama Financials
| SAME Stock | IDR 260.00 2.00 0.78% |
Sarana |
Understanding current and past Sarana Meditama Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Sarana Meditama's financial statements are interrelated, with each one affecting the others. For example, an increase in Sarana Meditama's assets may result in an increase in income on the income statement.
Sarana Meditama Stock Summary
Sarana Meditama competes with Siloam International, Mitra Keluarga, Adi Sarana, Elang Mahkota, and Prodia Widyahusada. PT Sarana Meditama Metropolitan Tbk, together with its subsidiaries, engages in the management of hospitals in Indonesia. PT Sarana Meditama Metropolitan Tbk is a subsidiary of PT Omni Health Care. Sarana Meditama is traded on Jakarta Stock Exchange in Indonesia.| Foreign Associate | Denmark |
| Instrument | Indonesia Stock View All |
| Exchange | Jakarta Exchange |
| ISIN | ID1000126303 |
| Business Address | Jalan Pulomas Barat |
| Sector | Health Care Providers & Services |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.emc.id |
| Phone | 62 21 2977 9977 |
| Currency | IDR - Indonesian Rupiah |
You should never invest in Sarana Meditama without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Sarana Stock, because this is throwing your money away. Analyzing the key information contained in Sarana Meditama's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Sarana Meditama Key Financial Ratios
Sarana Meditama's financial ratios allow both analysts and investors to convert raw data from Sarana Meditama's financial statements into concise, actionable information that can be used to evaluate the performance of Sarana Meditama over time and compare it to other companies across industries.| Return On Equity | -0.0035 | |||
| Return On Asset | 0.0015 | |||
| Target Price | 730.0 | |||
| Beta | 0.71 |
Sarana Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Sarana Meditama's current stock value. Our valuation model uses many indicators to compare Sarana Meditama value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Sarana Meditama competition to find correlations between indicators driving Sarana Meditama's intrinsic value. More Info.Sarana Meditama Metropolitan is rated second in return on equity category among its peers. It also is rated second in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Sarana Meditama's earnings, one of the primary drivers of an investment's value.Sarana Meditama Metr Systematic Risk
Sarana Meditama's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Sarana Meditama volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was three with a total number of output elements of fifty-eight. The Beta measures systematic risk based on how returns on Sarana Meditama Metr correlated with the market. If Beta is less than 0 Sarana Meditama generally moves in the opposite direction as compared to the market. If Sarana Meditama Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Sarana Meditama Metr is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Sarana Meditama is generally in the same direction as the market. If Beta > 1 Sarana Meditama moves generally in the same direction as, but more than the movement of the benchmark.
Sarana Meditama November 23, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Sarana Meditama help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Sarana Meditama Metropolitan. We use our internally-developed statistical techniques to arrive at the intrinsic value of Sarana Meditama Metropolitan based on widely used predictive technical indicators. In general, we focus on analyzing Sarana Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Sarana Meditama's daily price indicators and compare them against related drivers.
| Information Ratio | (0.09) | |||
| Maximum Drawdown | 18.07 | |||
| Value At Risk | (4.41) | |||
| Potential Upside | 5.48 |
Other Information on Investing in Sarana Stock
Sarana Meditama financial ratios help investors to determine whether Sarana Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sarana with respect to the benefits of owning Sarana Meditama security.